Login / Signup

Pricing New Drugs for COVID-19 in the Pharmaceutical Industry: Insights From the Chinese Medical Insurance.

Jinmiao LuXiao-Hua YingZhi-Ping Li
Published in: International journal of health policy and management (2023)
Keyphrases
  • coronavirus disease
  • sars cov
  • healthcare
  • health insurance
  • affordable care act
  • respiratory syndrome coronavirus
  • long term care
  • drug induced